相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Possible involvement of activation of P53/P21 and demethylation of RUNX 3 in the cytotoxicity against Lovo cells induced by 5-Aza-2′-deoxycytidine
Tao Deng et al.
LIFE SCIENCES (2009)
Radiation enhances adenoviral gene therapy in pancreatic cancer via activation of cytomegalovirus promoter and increased adenovirus uptake
Takuya Egami et al.
CLINICAL CANCER RESEARCH (2008)
Molecular-genetic imaging based on reporter gene expression
Joo Hyun Kang et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Epigenetic interplay between histone modifications and DNA methylation in gene silencing
Thomas Vaissiere et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Gene electrotransfer into murine skeletal muscle: A systematic analysis of parameters for long-term gene expression
Gregor Tevz et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2008)
Chemotherapeutic agents up-regulate the cytomegalovirus promoter:: implications for bioluminescence Imaging of tumor response to therapy
Robert U. Svensson et al.
CANCER RESEARCH (2007)
Non-invasive imaging in gene therapy (vol 15, pg 1579, 2007)
Jani Kristian Raety et al.
MOLECULAR THERAPY (2007)
Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells
Kwang Il Kim et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Epigenetic therapy of cancer with 5-aza-2′-deoxycytidine (decitabine)
RL Momparler
SEMINARS IN ONCOLOGY (2005)
Detection of plasmid DNA vectors following gene transfer to the murine airways
IA Pringle et al.
GENE THERAPY (2005)
Renal ischemia/reperfusion injury activates the enhancer domain of the human cytomegalovirus major immediate early promoter
SJ Kim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Analysis of signal transduction pathways in macrophages using expression vectors with CMV promoters:: A cautionary tale
Madhuri Ramanathan et al.
INFLAMMATION (2005)
Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: From bench top to bedside
BW O'Malley et al.
LARYNGOSCOPE (2005)
5-aza-cytidine is a potent inhibitor of DNA methyltransferase 3a and induces apoptosis in HCT-116 colon cancer cells via Gadd45-and p53-dependent mechanisms
R Schneider-Stock et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages
G Escher et al.
JOURNAL OF LIPID RESEARCH (2005)
5-aza-2′-deoxycytidine activates the p53/p21Waf1/Cip1 pathway to inhibit cell proliferation
WG Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle
AR Brooks et al.
JOURNAL OF GENE MEDICINE (2004)
NF-κB- and c-Jun-dependent regulation of human cytomegalovirus immediate-early gene enhancer/promoter in response to lipopolysaccharide and bacterial CpG-oligodeoxynucleotides in macrophage cell line RAW 264.7
Y Lee et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87
G Grassi et al.
CARCINOGENESIS (2003)
Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector
K Hong et al.
BIOMOLECULAR ENGINEERING (2001)
High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter
NS Yew et al.
MOLECULAR THERAPY (2001)
Regulation of adenovirus-mediated elafin transgene expression by bacterial lipopolysaccharide
AJ Simpson et al.
HUMAN GENE THERAPY (2001)
Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells
T Ritter et al.
CYTOKINE (2000)
分享论文
